UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. C型肝炎ウイルス感染と腎移植 hepatitis c virus infection and renal transplantation
- 2. 肺移植後の非感染性合併症 noninfectious complications following lung transplantation
- 3. 腎臓の同種移植片機能不全の鑑別診断 differential diagnosis of renal allograft dysfunction
- 4. 貧血と腎移植レシピエント anemia and the renal transplant recipient
- 5. 腎移植後患者の生存率 patient survival after renal transplantation
English Journal
- Radioimmunotherapy (90 Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab.
- Rossignol J1, Terriou L1, Robu D1, Willekens C1, Hivert B1, Pascal L1, Guieze R1, Trappe R2, Baillet C3, Huglo D3, Morschhauser F1.
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Jul;15(7):1976-1981. doi: 10.1111/ajt.13244. Epub 2015 Apr 13.
- Posttransplantation lymphoproliferative disorders (PTLDs) are life-threatening complications after solid organ and hematopoietic stem cell transplantation. Only half of CD20-positive PTLDs respond to rituximab monotherapy, and outcomes remain poor for patients with relapsed/refractory disease, espec
- PMID 25868706
- CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients.
- Lisboa LF1, Egli A2, Fairbanks J1, O'Shea D1, Manuel O3, Husain S4, Kumar D4, Humar A4.
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Jul;15(7):1882-1892. doi: 10.1111/ajt.13207. Epub 2015 Mar 12.
- Monitoring of cytomegalovirus cell-mediated immunity is a promising tool for the refinement of preventative and therapeutic strategies posttransplantation. Typically, the interferon-γ response to T cell stimulation is measured. We evaluated a broad range of cytokine and chemokines to better charact
- PMID 25764912
- Eculizumab Salvage Therapy for Antibody-Mediated Rejection in a Desensitization-Resistant Intestinal Re-Transplant Patient.
- Fan J1, Tryphonopoulos P1, Tekin A1, Nishida S1, Selvaggi G1, Amador A1, Jebrock J1, Weppler D2, Levi D3, Vianna R1, Ruiz P1, Tzakis A2.
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Jul;15(7):1995-2000. doi: 10.1111/ajt.13183. Epub 2015 Feb 3.
- The presence of elevated calculated panel reactive antibody (cPRA) and anti-HLA donor specific antibodies (DSA) are high risk factors for acute antibody-mediated rejection (AAMR) in intestinal transplantation that may lead to graft loss. Eculizumab has been used for the treatment of AAMR in kidney t
- PMID 25649227
Japanese Journal
- 生体肝移植7年後にinterface hepatitis を呈し特発性移植後肝炎と診断した1例
- 日本小児外科学会雑誌 52(2), 264-269, 2016
- NAID 130005147379
- 脳梗塞に対するヒト神経幹細胞移植後の内在性修復メカニズム―幹細胞は興奮性シナプスを増加させる―
- 脳循環代謝（日本脳循環代謝学会機関誌） 26(2), 151-154, 2015
- NAID 130005093687
- Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after cord blood transplantation
- 日本造血細胞移植学会雑誌 4(3), 74-81, 2015
- NAID 130005088498
Related Links
- Green M, Webber S. Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am. 2003 Dec. 50(6):1471-91. [Medline]. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Posttransplant lymphoproliferative ...
- Lymphoproliferative disorders (LPDs) can be parsed into the following 6 categories: Hodgkin disease Non-Hodgkin lymphoma Histiocytosis X Benign reactive lymphoproliferative disorders (including posttransplantation ...
Related Pictures
★リンクテーブル★
| リンク元 | 「移植後」「posttransplant」「postimplantation」「post-transplantation」 |
「移植後」
「posttransplant」
- 移植後の
「postimplantation」
- 移植後の
「post-transplantation」
- 移植後の